Biopharmaceutical
- All
- News
- Videos
-
How Iran Immigrant Maky Zanganeh Is Now A Self-Made Billionaire In US
Maky Zanganeh became a billionaire after shares of Summit Therapeutics, where she serves as co-CEO, soared following positive trial data for its promising cancer drug.
-
"I Donated To...": Biocon Head Kiran Mazumdar-Shaw On "Nominal" Electoral Bonds
Biocon Ltd Executive Chairperson Kiran Mazumdar-Shaw on Monday said that her Bengaluru-based biopharmaceuticals firm did not make any donations to any political party using electoral bonds.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
Concord Biotech, Vaibhav Gems Get Approval To Launch IPOs (Public Issue)
Concord is among the leading manufacturers of fermentation-based biopharmaceutical APIs focused on niche segments, such as immunosuppressant, oncology, anti-fungal and anti-bacterial.
-
"Devastated": Biocon Chief Kiran Mazumdar Shaw Mourns Vikram Kirloskar
Executive Chairperson of biopharmaceuticals Biocon Kiran Mazumdar-Shaw has expressed grief over the sudden demise of Vikram S. Kirloskar.
-
Samsung to Invest $356 Billion by 2026 to Accelerate Growth in Chip Sector, Biopharma, Next-Gen Technology
Samsung Electronics announced on Tuesday to invest $356 billion over the next five years in strategic sectors. The South Korean company is looking forward to accelerate long-term growth in semiconductors, biopharmaceutical and other next-generation technologies.
-
An Indian Pharma Is Working On Omicron-Specific Vaccine: Report
India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.
-
India's 1st Homegrown mRNA Vaccine Approved For More Clinical Trials
Pharmaceutical firm Gennova Biopharmaceuticals' COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday.
-
Samsung to Invest KRW 240 Trillion Over Next Three Years; Expand Into AI, Robotics, More Industries
Samsung Group will invest KRW 240 trillion (roughly Rs. 15,26,645 crores) in the next three years to expand footprint in biopharmaceutical, artificial intelligence, semiconductor, and robotics industries in the post-pandemic era, Samsung Electronics said.
-
25,000 Doses Of Remdesivir From Gilead Sciences Reach India
The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on Saturday.
-
Biocon Net Profit Jumps 105% To Rs 254 Crore In March Quarter
Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.
-
US Pharma Firm Gilead To Donate 4.5 Lakh Remdesivir Vials To India
American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India.
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
-
AstraZeneca Moves From Favored Child To Problem Child Among Vaccines
Mene Pangalos, head of biopharmaceuticals research for AstraZeneca Plc, went to bed on Monday, March 22, feeling good for the first time in a while.
-
India's First Homemade mRNA Vaccine Gets Permission To Start Human Trials
An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
-
How Iran Immigrant Maky Zanganeh Is Now A Self-Made Billionaire In US
Maky Zanganeh became a billionaire after shares of Summit Therapeutics, where she serves as co-CEO, soared following positive trial data for its promising cancer drug.
-
"I Donated To...": Biocon Head Kiran Mazumdar-Shaw On "Nominal" Electoral Bonds
Biocon Ltd Executive Chairperson Kiran Mazumdar-Shaw on Monday said that her Bengaluru-based biopharmaceuticals firm did not make any donations to any political party using electoral bonds.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
Concord Biotech, Vaibhav Gems Get Approval To Launch IPOs (Public Issue)
Concord is among the leading manufacturers of fermentation-based biopharmaceutical APIs focused on niche segments, such as immunosuppressant, oncology, anti-fungal and anti-bacterial.
-
"Devastated": Biocon Chief Kiran Mazumdar Shaw Mourns Vikram Kirloskar
Executive Chairperson of biopharmaceuticals Biocon Kiran Mazumdar-Shaw has expressed grief over the sudden demise of Vikram S. Kirloskar.
-
Samsung to Invest $356 Billion by 2026 to Accelerate Growth in Chip Sector, Biopharma, Next-Gen Technology
Samsung Electronics announced on Tuesday to invest $356 billion over the next five years in strategic sectors. The South Korean company is looking forward to accelerate long-term growth in semiconductors, biopharmaceutical and other next-generation technologies.
-
An Indian Pharma Is Working On Omicron-Specific Vaccine: Report
India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.
-
India's 1st Homegrown mRNA Vaccine Approved For More Clinical Trials
Pharmaceutical firm Gennova Biopharmaceuticals' COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday.
-
Samsung to Invest KRW 240 Trillion Over Next Three Years; Expand Into AI, Robotics, More Industries
Samsung Group will invest KRW 240 trillion (roughly Rs. 15,26,645 crores) in the next three years to expand footprint in biopharmaceutical, artificial intelligence, semiconductor, and robotics industries in the post-pandemic era, Samsung Electronics said.
-
25,000 Doses Of Remdesivir From Gilead Sciences Reach India
The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on Saturday.
-
Biocon Net Profit Jumps 105% To Rs 254 Crore In March Quarter
Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.
-
US Pharma Firm Gilead To Donate 4.5 Lakh Remdesivir Vials To India
American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India.
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
-
AstraZeneca Moves From Favored Child To Problem Child Among Vaccines
Mene Pangalos, head of biopharmaceuticals research for AstraZeneca Plc, went to bed on Monday, March 22, feeling good for the first time in a while.
-
India's First Homemade mRNA Vaccine Gets Permission To Start Human Trials
An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
